Cargando…
The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inf lammatory arthritis; however, they also possess a potential risk for serious infection. Recently, with the rapid expansion of the bDMARDs market in Korea, reports of serious adverse events...
Autores principales: | Park, Eun-Jung, Kim, Hyungjin, Jung, Seung Min, Sung, Yoon-Kyoung, Baek, Han Joo, Lee, Jisoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960050/ https://www.ncbi.nlm.nih.gov/pubmed/31935319 http://dx.doi.org/10.3904/kjim.2019.411 |
Ejemplares similares
-
Quality Indicators for Evaluating the Health Care of Patients with Rheumatoid Arthritis: a Korean Expert Consensus
por: Seo, Mi Ryoung, et al.
Publicado: (2021) -
Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association
por: Cho, Yuri, et al.
Publicado: (2023) -
Standardized Imaging and Reporting for Thyroid Ultrasound: Korean Society of Thyroid Radiology Consensus Statement and Recommendation
por: Lee, Min Kyoung, et al.
Publicado: (2023) -
Chinese expert consensus on the treatment of MMD
por: Bao, Xiang-Yang, et al.
Publicado: (2023) -
2023 APHRS expert consensus statements on surgery for AF
por: Nitta, Takashi, et al.
Publicado: (2023)